S. Gordon

424 total citations
14 papers, 295 citations indexed

About

S. Gordon is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, S. Gordon has authored 14 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 9 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in S. Gordon's work include Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (4 papers). S. Gordon is often cited by papers focused on Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (4 papers). S. Gordon collaborates with scholars based in United States, China and Türkiye. S. Gordon's co-authors include Ronald A. Meyer, Ann L. Silverman, E. Schiff, Y. Benhamou, Nezam H. Afdhal, Yoav Lurie, Brittany L. Murphy, Paul J. Pockros, Patrick Marcellin and M. Shiffman and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

S. Gordon

14 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Gordon United States 9 221 213 59 30 25 14 295
Pierluigi Blanc Italy 9 119 0.5× 94 0.4× 64 1.1× 6 0.2× 24 1.0× 18 246
M. Lagget Italy 14 424 1.9× 381 1.8× 51 0.9× 6 0.2× 31 1.2× 27 516
R. Cuppone Italy 9 199 0.9× 192 0.9× 20 0.3× 6 0.2× 6 0.2× 17 301
Feng Su United States 8 322 1.5× 337 1.6× 44 0.7× 6 0.2× 7 0.3× 13 428
S. Carenzi Italy 7 459 2.1× 409 1.9× 32 0.5× 16 0.5× 4 0.2× 14 488
Dominic Dell Olio Italy 9 122 0.6× 177 0.8× 24 0.4× 8 0.3× 18 0.7× 18 312
Steven Shev Sweden 10 359 1.6× 360 1.7× 51 0.9× 5 0.2× 18 0.7× 11 453
Giuseppe Barbaro Italy 8 261 1.2× 245 1.2× 62 1.1× 6 0.2× 8 0.3× 9 356
Katharina Willuweit Germany 9 111 0.5× 154 0.7× 90 1.5× 24 0.8× 7 0.3× 35 280
Rachele Rapetti Italy 8 237 1.1× 212 1.0× 26 0.4× 16 0.5× 15 306

Countries citing papers authored by S. Gordon

Since Specialization
Citations

This map shows the geographic impact of S. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Gordon more than expected).

Fields of papers citing papers by S. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Gordon. The network helps show where S. Gordon may publish in the future.

Co-authorship network of co-authors of S. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of S. Gordon. A scholar is included among the top collaborators of S. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Gordon. S. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gordon, S., Terry L. Levin, Patricia Friedmann, et al.. (2021). Is necrotizing enterocolitis the same disease in term and preterm infants?. Journal of Pediatric Surgery. 56(8). 1370–1374. 11 indexed citations
2.
Läwitz, E., Zobair M. Younossi, M. Shiffman, et al.. (2009). 628 RANDOMIZED TRIAL COMPARING SYSTEMIC AND LOCAL REACTIONS TO CONTROLLED-RELEASE INTERFERON ALPHA2B AND PEGYLATED-INTERFERON ALPHA2B IN HEPATITIS C PATIENTS WHO FAILED PRIOR TREATMENT. Journal of Hepatology. 50. S231–S231. 6 indexed citations
3.
Chang, Ting‐Tsung, Ching‐Lung Lai, Kwang‐Hyub Han, et al.. (2008). Efficacy of Entecavir in Nucleoside-Naïve Patients with Mildly Elevated ALT. 1 indexed citations
4.
Schiff, E., F. Poordad, Ira M. Jacobson, et al.. (2008). 104 BOCEPREVIR (B) COMBINATION THERAPY IN NULL RESPONDERS (NR): RESPONSE DEPENDENT ON INTERFERON RESPONSIVENESS. Journal of Hepatology. 48. S46–S46. 37 indexed citations
5.
6.
Venick, Robert S., Douglas G. Farmer, S. Gordon, et al.. (2006). Nutritional Outcomes Following Pediatric Intestinal Transplantation. Transplantation Proceedings. 38(6). 1718–1719. 18 indexed citations
7.
8.
Trépo, Christian, Karen L. Lindsay, C. Niederau, et al.. (2000). Pegylated interferon alfa-2B (PEG-intron) mono-therapy is superior to interferon alfa-2B (intron A) for the treatment of chronic hepatitis C. Journal of Hepatology. 32. 29–29. 23 indexed citations
9.
Krawitt, E. L., Anil John, Marshall Kaplan, et al.. (1998). Preliminary results of the NYNEST interferon-Ribavirin re-treatment trial in non-responders and relapsers with chronic hepatitis C. Gastroenterology. 114. A1280–A1280. 2 indexed citations
10.
Simon, Douglas, S. Gordon, Marshall M. Kaplan, et al.. (1997). Treatment of Chronic Hepatitis C With Interferon Alfa–N3: A Multicenter, Randomized, Open–Label Trial. Hepatology. 25(2). 445–448. 15 indexed citations
11.
Silverman, Ann L., et al.. (1994). HCV RNA is present in the menstrual blood of women with chronic hepatitis C infection.. PubMed. 89(8). 1201–2. 20 indexed citations
12.
Gordon, S., et al.. (1994). Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis.. PubMed. 89(10). 1836–9. 86 indexed citations
13.
Barnes, Robert, Ronald A. Meyer, & S. Gordon. (1992). Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community.. PubMed. 87(8). 1001–4. 6 indexed citations
14.
Meyer, Ronald A. & S. Gordon. (1991). Epidemiology of hepatitis C virus infection in a suburban Detroit community.. PubMed. 86(9). 1224–6. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierluigi Blanc Breakdown of academic impact, for papers by M. Lagget Breakdown of academic impact, for papers by R. Cuppone Breakdown of academic impact, for papers by Feng Su Breakdown of academic impact, for papers by S. Carenzi Breakdown of academic impact, for papers by Dominic Dell Olio Breakdown of academic impact, for papers by Steven Shev Breakdown of academic impact, for papers by Giuseppe Barbaro Breakdown of academic impact, for papers by Katharina Willuweit Breakdown of academic impact, for papers by Rachele Rapetti
Rankless by CCL
2026